Ps. Murali et al., INVESTIGATIONS INTO THE CELLULAR IMMUNE-RESPONSES IN LATEX ALLERGY, The Journal of laboratory and clinical medicine, 124(5), 1994, pp. 638-643
Citations number
31
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
Latex allergy is a hypersensitivity response to allergens in the natur
al latex products. Skin prick tests, which do not correlate very well
with latex-specific immunoglobulin E (IgE), are yet the only reliable
diagnostic tools for clinically determining hypersensitivity to latex
In this study, patients who were skin test (SPT) positive with (STP+/A
NA+) or without (SPT+/ANA-) history of anaphylaxis formed the test gro
ups. Healthy volunteers (SPT-/ANA-) served as controls. Lymphocyte pro
liferation in response to crude and purified latex antigens, serum imm
unoglobulin E-total, and latex-specific and in vitro immunoglobulin E
(IgE) production in response to crude latex antigens were studied. Res
ults indicate that both patient groups showed enhanced response to lat
ex antigen by lymphoproliferation. In patient groups this response to
the different antigens tested, or to crude versus purified antigens, w
as not statistically different. Serum total IgE (ng/ml) was elevated i
n patients (range, SPT+/ANA-, 40 to 1250; SPT+/ANA+, 40 to 4550) when
compared with controls (40 to 450). Low levels (1 to 3 ng/ml) of IgE w
ere detected in the peripheral blood mononuclear cell culture supernat
ants from the patient groups. These levels were less than or equal to
1 ng/ml in the control group. Significant levels of IgE (log titer, me
an +/- SD) specific to MFL1 and glove antigens were measured in serum
from both SPT+/ANA- (MFL1, 1.85 +/- 0.23, p < 0.001; glove, 1.81 +/- 0
.23, p < 0.001) and SPT+/ANA- (MFL1, 1.92 +/- 0.39, p < 0.007; glove 1
.85 +/- 0.4, p < 0.006) end compared with results from the control gro
up (MFL1, 1.50 +/- 0.1; glove, 1.38 +/- 0.19). These results indicate
that similar immunologic testing of a larger number of latex allergens
may provide material that could be used safely and efficiently for di
agnosis or as immunomodulatory agents in therapy.